Cymabay Therapeutics Total Revenue

Cymabay Therapeutics (CBAY) currently reports a total revenue of $31M as of December 2023. In the prior-year period, the figure was $0. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Cymabay Therapeutics's total revenue history and peer comparisons.

Cymabay Therapeutics's total revenue changed from $0 to $31M (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cymabay Therapeutics's total revenue of $31M is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Cymabay Therapeutics reported $31M in total revenue as of December 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $31M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Cymabay Therapeutics, and consider following CBAY for alerts when major investors trade the stock.